Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency
Author:
Funder
Italian Ministry of Education, University and Research
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference33 articles.
1. The liposomal formulation of doxorubicin;Abraham;Methods Enzymol.,2005
2. Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells;Amin;Int. J. Nanomed.,2018
3. Diffusion of univalent ions across the lamellae of swollen phospholipids;Bangham;J Mol. Biol.,1965
4. pH-controlled liposomes for enhanced cell penetration in tumor environment;Barattin;ACS Appl. Mater. Interfaces,2018
5. Doxil® — The first FDA-approved nano-drug: lessons learned;Barenholz;J. Control Release,2012
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development;Cellular Signalling;2024-05
2. Enhancing drug penetration in solid tumors via nanomedicine: Evaluation models, strategies and perspectives;Bioactive Materials;2024-02
3. Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery;Journal of Controlled Release;2023-11
4. Organic disulfide crosslinked nucleic acid-based nanocarriers for anticancer drug applications;Journal of Drug Delivery Science and Technology;2023-09
5. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin;Pharmaceutics;2023-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3